Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is […]
Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.
Patients “will bear the brunt of this hardship” says Jump, who […]
Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the […]
The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an in-depth highlight session on the paclitaxel controversy. […]
Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.
Hayes talks about the accuracy of the device’s deployment around the thoracic […]
Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about the “limitations of the current clunky stenting paradigm” and how the […]
A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.
Opening the session, Stéphan Haulon and his team […]
Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session.
Industry leaders say approximately 50% of all medical devices will be withdrawn from the market; around 30% of manufacturers will not survive and patients might be at risk as a result of the European Medical Device Regulation (EU MDR), which is described by some as the “most disruptive force to […]
New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon aloneAnthony Strzalek2019-09-06T16:10:43+01:00
Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]
The CX Innovation Programme showcased technological developments happening in all areas of the Charing Cross Symposium: acute stroke, aortic, peripheral, venous, vascular access, and wound care. Additionally, a new “Dragons’ Den” winner was crowned.
In the first talk of the session, Lindsay Machan (Vancouver, Canada) talked about the lessons he had learnt from being a founder […]
Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]
New MIMICS-2 trial data show helical stents provide durable treatment of diseased femoropopliteal arteriesEditorial2019-09-06T16:12:16+01:00
New data from the MIMICS-2 trial show the BioMimics 3D stent, which mimics natural vascular curvature, remains safe and effective for patients with symptomatic atherosclerotic disease of the femoropopliteal arteries two years after implantation.
Principal investigator Timothy Sullivan (Minnesota, USA) presented the two-year findings at this year’s Charing […]
Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and the future role of diffusion-weighted magnetic resonance imaging (DW-MRI) in reducing stroke from endovascular repair. The multicentre dataset was presented at a Charing […]
Endovascular repair matches open surgery for treatment of men with complex but low-risk aortoiliac disease using self-expanding covered stentsEditorial2019-04-18T17:16:33+01:00
Endovascular repair shortens hospital stay and has comparable outcomes to open surgery when balloon-expandable covered stents are used to treat low-risk male patients with complex aortoiliac lesions, new data show. Michele Antonello (Padua, Italy), described some of the study’s key results during a presentation at […]
Interventionists can confidently use lower profile drug delivery platforms, based on data that shows 0.018-inch guidewire devices are non-inferior to 0.035-inch guidewires. In a Podium 1st presentation at Charing Cross (CX) Symposium on Thursday, Andrew Holden (Auckland, New Zealand) said: “At 90 days, we can […]
Tilo Kölbel’s team, led on site in Hamburg, Germany, by Giuseppe Panuccio, successfully performed a thoracic endovascular aortic repair (TEVAR) on a 77-year old female patient with American Stroke Association (ASA) class III, and multiple aortic aneurysm disease with multiple aneurysms. The live case was viewed by […]
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.
Edmonds discusses why “too many legs are being lost” and Serena talks […]
Using EndoAnchors to fix and seal endovascular aortic grafts is safe and effective for short-neck abdominal aortic aneurysm (AAA) patients, two-year data from the ANCHOR global registry have shown. Frank Arko (Charlotte, USA) presented the findings yesterday at CX Symposium in a podium first session, […]
As part of Wednesday’s CX Vascular Access Workshop in the Pillar Hall Learning Centre, there was a section of the programme on drug-coated balloon trial updates which ended with a panel discussion on whether peripheral vascular disease data is applicable to vascular access. The discussion […]
Yesterday, during the Aortic Podium 1st session, Fabio Verzini (Turin, Italy) reported that endovascular aneurysm repair (EVAR) with an iliac branch endoprothesis (Gore) is safe and effective. He added that the procedure was associated with improved quality of life in the short term and […]
For the first time, the Charing Cross (CX) audience has been able to experience an array of virtual reality live cases in both the peripheral and aortic programmes. The virtual reality live streaming in 360° video, accompanied by a running commentary by the operator, provided a […]
The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the National Institute for Health and Care Excellence (NICE), set to go against widespread endovascular practice in recommending open repair over EVAR. In May […]
Across the globe, vascular recruitment is struggling. This was the reason why delegates convened in the Upper Auditorium yesterday afternoon for a CX Highlight Session dedicated to the topic, where representatives from three continents explained exactly how and why the vascular specialty is experiencing this […]
Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”
Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]